Help | Sitemap | Archive | Advanced Search   
  CHINA
  BUSINESS
  OPINION
  WORLD
  SCI-EDU
  SPORTS
  LIFE
  WAP SERVICE
  FEATURES
  PHOTO GALLERY

Message Board
Feedback
Voice of Readers
 China At a Glance
 Constitution of the PRC
 CPC and State Organs
 Chinese President Jiang Zemin
 White Papers of Chinese Government
 Selected Works of Deng Xiaoping
 English Websites in China
Help
About Us
SiteMap
Employment

U.S. Mirror
Japan Mirror
Tech-Net Mirror
Edu-Net Mirror
 
Friday, July 20, 2001, updated at 18:28(GMT+8)
Business  

Everpride Biopharmaceutical Lists on HK GEM

Everpride Biopharmaceutical (Everpride), a company from the Chinese mainland, is listed on Hong Kong Growth Enterprises Market (GEM) Friday, raising around 60 million Hong Kong dollars (about 7.69 million U.S. dollars).

Everpride offered 140 million new shares by way of placing with the offer price 0.495 Hong Kong dollars (about 6.35 U.S. cents) per share and the subscription rate was more than 10 times. The sponsor and lead manager is DBS Asia Capital Limited.

Everpride set up in 1995 with its headquarters in Taigu County of Shanxi province. Currently, its core product is a product of Chinese medicine called "Plasmin Capsule." The product passed an import clearance from the U.S. Customs and FDA.

Chung Chi Mang, chairman of Everpride, believes the listing of Everpride on GEM can enhance its corporate profile.

He said the company would put emphasize on the research and development on cardiovascular and cerebrovascular diseases and new products in the future.

At the same time, Everpride would enhance its sales and distribution network and further develop the overseas markets, he added.







In This Section
 

Everpride Biopharmaceutical (Everpride), a company from the Chinese mainland, is listed on Hong Kong Growth Enterprises Market (GEM) Friday, raising around 60 million Hong Kong dollars (about 7.69 million U.S. dollars).

Advanced Search


 


 


Copyright by People's Daily Online, all rights reserved